CardioNet, Inc. Announces Launch of MCOTos 2:1 Device
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CONSHOHOCKEN, Pa., June 19, 2013 (GLOBE NEWSWIRE) -- CardioNet, Inc. (Nasdaq:BEAT) ("CardioNet"), the leading wireless medical technology company focused on diagnosing and monitoring cardiac arrhythmias, announced today the launch of the MCOTos 2:1 device, providing both MCOTTM and wEvent monitoring capability in a single device. This added feature provides increased flexibility and convenience to both physicians and patients.
Help employers find you! Check out all the jobs and post your resume.
CONSHOHOCKEN, Pa., June 19, 2013 (GLOBE NEWSWIRE) -- CardioNet, Inc. (Nasdaq:BEAT) ("CardioNet"), the leading wireless medical technology company focused on diagnosing and monitoring cardiac arrhythmias, announced today the launch of the MCOTos 2:1 device, providing both MCOTTM and wEvent monitoring capability in a single device. This added feature provides increased flexibility and convenience to both physicians and patients.
Help employers find you! Check out all the jobs and post your resume.